Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation.
The progress in anti-platelet therapy and percutaneous coronary intervention led to reconfigure indications of hybrid re-vascularisation. However, there are still some controversies over indication, timing and patient management during the procedure. The case discussed here is a patient who was diagnosed with myocardial infarction and treated with hybrid re-vascularisation. The patient underwent stent insertion followed by bypass surgery. After the hybrid procedure, the patient was stable but eventually died on the 12th day after the surgery owing to unexpected stent thrombosis. We discuss the current controversy over hybrid re-vascularisation, variables that can affect the outcome and the requirement for establishing accurate logistics based on our case.
Shim
Jae Hoon
JH
Department of Thoracic and Cardiovascular Surgery, Ansan Hospital, Korea University Medical Center, Korea University, Gojan-1-dong, Ansan-si, Kyonggi-do 425-707, South Korea.
Jo
Won-Min
WM
Chung
Won Jae
WJ
Chung
Jae Ho
JH
D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D047549:Coronary Artery Bypass, Off-Pump / Q000009:adverse effects* / Q000379:methods; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000209:etiology*; D017809:Fatal Outcome; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015607:Stents
D010975:Platelet Aggregation Inhibitors